Early research has claimed that TGF-β1 encourages long-term rises in neuronal excitability in Aplysia (Chin et al., 2006), and that TGF-β2 treatment of cultured hippocampal neurons decreases short-term synaptic depression (Fukushima et al., 2007). This evidence concerns the gene TGFB2 and depressive symptom measurement.